Molecular targeted therapy of biliary tract cancer--results of the first clinical studies

scientific article published on July 2010

Molecular targeted therapy of biliary tract cancer--results of the first clinical studies is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.2174/138945010791320818
P698PubMed publication ID20388063

P2093author name stringJoachim Mössner
Marcus W Wiedmann
P433issue7
P304page(s)834-850
P577publication date2010-07-01
P1433published inCurrent Drug TargetsQ15724627
P1476titleMolecular targeted therapy of biliary tract cancer--results of the first clinical studies
P478volume11

Reverse relations

cites work (P2860)
Q58605334Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell
Q33392786Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.
Q34959174Cholangiocarcinoma: molecular pathways and therapeutic opportunities
Q38701620Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer.
Q37866791Combining biological agents and chemotherapy in the treatment of cholangiocarcinoma.
Q38152382Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting
Q36582547Evaluation of phosphatidylinositol-3-kinase catalytic subunit (PIK3CA) and epidermal growth factor receptor (EGFR) gene mutations in pancreaticobiliary adenocarcinoma
Q53393758Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
Q92837764High expression of brain-derived neurotrophic factor in intrahepatic cholangiocarcinoma is associated with intraneural invasion and unfavorable prognosis
Q50972322Platelet-derived growth factor D: a new player in the complex cross-talk between cholangiocarcinoma cells and cancer-associated fibroblasts.
Q36822722Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells
Q92875468Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications
Q38949695Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway
Q39625434Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas
Q39434606Targeting PDGFR-β in Cholangiocarcinoma
Q50350640The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Q37081350The effect of regular exercise on development of sarcoma tumor and oxidative damage in mice liver
Q39422598The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines
Q37964960The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma
Q38584340Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?

Search more.